Neuropathology provides clues to the pathophysiology of Gaucher disease

Molecular Genetics and Metabolism

Volumn 82, Issue 3, 2004, Pages 192-207

  Wong, Kondi ^a   Sidransky, Ellen ^b   Verma, Ajay ^c   Mixon, Tonghui ^a   Sandberg, Glenn D ^a   Wakefield, Laura K ^a   Morrison, Alan ^a   Lwin, Alicia ^b   Colegial, Carlos ^a   Allman, John M ^d   Schiffmann, Raphael ^e  

^a Dept Neuropathology Armed Forces I ^*  (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Astrogliosis; Calcarine cortex; Gaucher disease; Glucocerebrosidase; Hippocampus; Lewy body; Neuronal loss; Parkinsonism; Synuclein

Indexed keywords

GLUCOSYLCERAMIDE; SYNUCLEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOSIS; AUTORADIOGRAPHY; BRAIN CORTEX; BRAIN DISEASE; BRAIN DYSFUNCTION; BRAIN NERVE CELL; BRAIN STEM; CALCIUM TRANSPORT; CHEMICAL ANALYSIS; CHILD; CLINICAL ARTICLE; CYTOTOXICITY; DEMENTIA; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; GAUCHER DISEASE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; MALE; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSITIZATION;

ADOLESCENT; AGED; AGED, 80 AND OVER; ANIMALS; ASTROCYTES; AUTORADIOGRAPHY; BRAIN; CALCIUM RADIOISOTOPES; CHILD; CHILD, PRESCHOOL; EPILEPSIES, MYOCLONIC; FEMALE; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURONS; RATS; SYNUCLEINS;

EID: 3242703423     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymgme.2004.04.011     Document Type: Article

References (88)

1. Brady R.O., Kanfer J.N., Bradley R.M., Shapiro D. Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher disease. J. Clin. Invest. 45:1966;1112-1115
2. Beutler E., Grabowski G.A. Gaucher disease. Scriver C.R., et al. Metabolic and Molecular Basis of Inherited Disease. 2001;3635-3668 McGraw-Hill, New York
3. Brady R.O., Barranger J.A. Glucosylceramide lipidosis: Gaucher disease. Stanbury J.B., et al. The Metabolic Basis of Inherited Disease. 1983;842-856 McGraw-Hill, New York
4. Ginns E.I., Brady R.O., Pirruccello S., Moore C., Sorrell S., Furbish F.S., Murray G.J., Tager J., Barranger J.A. Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease. Proc. Natl. Acad. Sci. USA. 79:1982;5607-5610
5. Ginns E.I., Tegelaers F.P., Barneveld R., Galjaard H., Reuser A.J., Brady R.O., Tager J.M., Barranger J.A. Determination of Gaucher disease phenotypes with monoclonal antibody. Clin. Chim. Acta. 131:1983;283-287
6. Brady R.O. Sphingolipidoses. Annu. Rev. Biochem. 47:1978;687-713
7. Miller J.D., McCluer R., Kanfer J.N. Gaucher disease: neurologic disorder in adult siblings. Ann. Intern. Med. 78:1973;883-887
8. Vellodi A., Bembi B., de Villemeur T.B., Collin-Histed T., Erikson A., Mengel E., Rolfs A., Tylki-Szymanska A. Management of neuronopathic Gaucher disease: a European consensus. J. Inherit. Metab. Dis. 24:2001;319-327
9. Niemann A. Ein unbekanntes Krankheitsbild. Jahrb f Kinderheilk. 1914;1-10
10. Gaucher P.C.E. De L'epithelioma primitif de la rate hypertrophie idiopathique de la rate sans leucemie Medicine. 1882;University of Paris, Paris
11. Adachi M., Wallace B.J., Schneck L., Volk B.W. Fine structure of central nervous system in early infantile Gaucher disease. Arch. Pathol. 83:1967;513-526
12. Banker B.Q.M.J. The Cerebral Pathology of Infantile Gaucher Disease. 1962;Academic Press, New York. pp. 73-79
13. Norman R.M., Lloyd O.C. The neuropathology of infantile Gaucher disease. J. Pathol. Bacteriol. 72:1956
14. Lee R.E. The Pathology of Gaucher Disease. 1982;Alan R. Liss, New York. pp. 177-217
15. Kaye E.M., Ullman M.D., Wilson E.R., Barranger J.A. Type 2 and type 3 Gaucher disease: a morphological and biochemical study. Ann. Neurol. 20:1986;223-230
16. Espinas O.E., Faris A.A. Acute infantile Gaucher disease in identical twins. An account of clinical and neuropathologic observations. Neurology. 19:1969;133-140
17. Conradi N., Kyllerman M., Mansson J.E., Percy A.K., Svennerholm L. Late-infantile Gaucher disease in a child with myoclonus and bulbar signs: neuropathological and neurochemical findings. Acta Neuropathol. (Berl.). 82:1991;152-157
18. Conradi N.G., Sourander P., Nilsson O., Svennerholm L., Erikson A. Neuropathology of the Norrbottnian type of Gaucher disease. Morphological and biochemical studies. Acta Neuropathol. (Berl.). 65:1984;99-109
19. Conradi N.G., Kalimo H., Sourander P. Reactions of vessel walls and brain parenchyma to the accumulation of Gaucher cells in the Norrbottnian type (type III) of Gaucher disease. Acta Neuropathol. (Berl.). 75:1988;385-390
20. Neil J.F., Glew R.H., Peters S.P. Familial psychosis and diverse neurologic abnormalities in adult-onset Gaucher disease. Arch. Neurol. 36:1979;95-99
21. Soffer D., Yamanaka T., Wenger D.A., Suzuki K. Central nervous system involvement in adult-onset Gaucher disease. Acta Neuropathol. (Berl.). 49:1980;1-6
22. Van Bogaert L.F. Un cas de maladie de Gaucher de l'adulte avec syndrome de Raynaud, pigmentation, et rigidite du type extra-pyrajidal aux membres inferieurs. Ann. Med. 45:1939;57-70
23. McKeran R.O., Bradbury P., Taylor D., Stern G. Neurological involvement in type 1 (adult) Gaucher disease. J. Neurol. Neurosurg. Psychiatry. 48:1985;172-175
24. Neudorfer O., Giladi N., Elstein D., Abrahamov A., Turezkite T., Aghai E., Reches A., Bembi B., Zimran A. Occurrence of Parkinson's syndrome in type I Gaucher disease. QJM. 89:1996;691-694
25. Machaczka M., Rucinska M., Skotnicki A.B., Jurczak W. Parkinson's syndrome preceding clinical manifestation of Gaucher disease. Am. J. Hematol. 61:1999;216-217
26. Varkonyi J., Rosenbaum H., Baumann N., MacKenzie J.J., Simon Z., Aharon-Peretz J., Walker J.M., Tayebi N., Sidransky E. Gaucher disease associated with parkinsonism: four further case reports. Am. J. Med. Genet. 116A:2003;348-351
27. Tayebi N., Callahan M., Madike V., Stubblefield B.K., Orvisky E., Krasnewich D., Fillano J.J., Sidransky E. Gaucher disease and parkinsonism: a phenotypic and genotypic characterization. Mol. Genet. Metab. 73:2001;313-321
28. Tayebi N., Walker J., Stubblefield B., Orvisky E., LaMarca M.E., Wong K., Rosenbaum H., Schiffmann R., Bembi B., Sidransky E. Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol. Genet. Metab. 79:2003;104-109
29. Fogli A., Wong K., Eymard-Pierre E., Wenger J., Bouffard J.P., Goldin E., Black D.N., Boespflug-Tanguy O., Schiffmann R. Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus. Ann. Neurol. 52:2002;506-510
30. Barneveld R.A., Tegelaers F.P., Ginns E.I., Visser P., Laanen E.A., Brady R.O., Galjaard H., Barranger J.A., Reuser A.J., Tager J.M. Monoclonal antibodies against human beta-glucocerebrosidase. Eur. J. Biochem. 134:1983;585-589
31. Verma A., Hirsch D.J., Snyder S.H. Calcium pools mobilized by calcium or inositol 1,4,5-trisphosphate are differentially localized in rat heart and brain. Mol. Biol. Cell. 3:1992;621-631
32. Verma A., Hirsch D.J., Hanley M.R., Thastrup O., Christensen S.B., Snyder S.H. Inositol trisphosphate and thapsigargin discriminate endoplasmic reticulum stores of calcium in rat brain. Biochem. Biophys. Res. Commun. 172:1990;811-816
33. Verma A., Ross C.A., Verma D., Supattapone S., Snyder S.H. Rat brain endoplasmic reticulum calcium pools are anatomically and functionally segregated. Cell Regul. 1:1990;781-790
34. Lloyd-Evans E., Pelled D., Riebeling C., Bodennec J., de-Morgan A., Waller H., Schiffmann R., Futerman A.H. Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms. J. Biol. Chem. 278:2003;23594-23599
35. Garvey M.A., Toro C., Goldstein S., Altarescu G., Wiggs E.A., Hallett M., Schiffmann R. Somatosensory evoked potentials as a marker of disease burden in type 3 Gaucher disease. Neurology. 56:2001;391-394
36. Gwinn-Hardy K., Mehta N.D., Farrer M., Maraganore D., Muenter M., Yen S.H., Hardy J., Dickson D.W. Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p. Acta Neuropathol. (Berl.). 99:2000;663-672
37. Haltia M., Herva R., Suopanki J., Baumann M., Tyynela J. Hippocampal lesions in the neuronal ceroid lipofuscinoses. Eur. J. Paediatr. Neurol. 5(Suppl. A):2001;209-211
38. Cajal R.Y. Histologie du Systeme Nerveux de l'Homme et des VertebresVolume II. 1911;Maloine, Paris
39. Johnston D., Brown T.H. Giant synaptic potential hypothesis for epileptiform activity. Science. 211:1981;294-297
40. Radpour S., Thomson A.M. Coactivation of local circuit NMDA receptor mediated epsps induces lasting enhancement of minimal schaffer collateral epsps in slices of rat hippocampus. Eur. J. Neurosci. 3:1991;602-613
41. Johnston D., Amaral D.G. Hippocampus. Shepard G.M. The Synaptic Organization of the Brain. 1998;429-457 Oxford University Press, New York
42. Tamamaki N., Abe K., Nojyo Y. Columnar organization in the subiculum formed by axon branches originating from single CA1 pyramidal neurons in the rat hippocampus. Brain Res. 412:1987;156-160
43. Amaral D.G., Dolorfo C., Alvarez-Royo P. Organization of CA1 projections to the subiculum: a PHA-L analysis in the rat. Hippocampus. 1:1991;415-435
44. Miles R., Wong R.K. Excitatory synaptic interactions between CA3 neurones in the guinea-pig hippocampus. J. Physiol. 373:1986;397-418
45. MacVicar B.A., Dudek F.E. Local synaptic circuits in rat hippocampus: interactions between pyramidal cells. Brain Res. 184:1980;220-223
46. Ishizuka N., Cowan W.M., Amaral D.G. A quantitative analysis of the dendritic organization of pyramidal cells in the rat hippocampus. J. Comp. Neurol. 362:1995;17-45
47. Li X.G., Somogyi P., Ylinen A., Buzsaki G. The hippocampal CA3 network: an in vivo intracellular labeling study. J. Comp. Neurol. 339:1994;181-208
48. Traub R.D., Miles R. Multiple modes of neuronal population activity emerge after modifying specific synapses in a model of the CA3 region of the hippocampus. Ann. N. Y. Acad. Sci. 627:1991;277-290
49. Johnston D., Brown T.H. The synaptic nature of the paroxysmal depolarizing shift in hippocampal neurons. Ann. Neurol. 16(Suppl.):1984;S65-S71
50. Johnston D., Brown T.H. Control Theory Applied to Neural Networks Illuminates Synaptic Basis of Interictal Epileptiform Activity. 1986;Raven Press, New York. pp. 263-274
51. Johnston D., Brown T.H. Mechanisms of Neuronal Burst Generation. 1984;Academic Press, London. pp. 277-301
52. Eng L.F., Yu A.C., Lee Y.L. Astrocytic response to injury. Prog. Brain Res. 94:1992;353-365
53. Miller K.K., Verma A., Snyder S.H., Ross C.A. Localization of an endoplasmic reticulum calcium ATPase mRNA in rat brain by in situ hybridization. Neuroscience. 43:1991;1-9
54. 2+ and other cation-transporting ATPases using an oligonucleotide probe derived from the ATP-binding site. J. Biol. Chem. 263:1988;15032-15040
55. Korkotian E., Schwarz A., Pelled D., Schwarzmann G., Segal M., Futerman A.H. Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons. J. Biol. Chem. 274:1999;21673-21678
56. Polyak S.L. The Vertebrate Visual System. 1957;University of Chicago Press, Chicago
57. Brodemann K. Vergleichende Lokalisation-slehre der Grosshirnrinde. 1909;Barth Press, Leipzig
58. Fitzpatrick D., Lund J.S., Blasdel G.G. Intrinsic connections of macaque striate cortex: afferent and efferent connections of lamina 4C. J. Neurosci. 5:1985;3329-3349
59. Spatz W.B. Thalamic and other subcortical projections to area MT (visual area of superior temporal sulcus) in the marmoset Callithrix jacchus. Brain Res. 99:1975;129-134
60. Tigges J., Tigges M., Anschel S., Cross N.A., Letbetter W.D., McBride R.L. Areal and laminar distribution of neurons interconnecting the central visual cortical areas 17, 18, 19, and MT in squirrel monkey (Saimiri). J. Comp. Neurol. 202:1981;539-560
61. Allman J.M., McGuinness E.R. Visual Cortex in Primates. 1988;279-326 Alan R. Liss, Los Angeles
62. Rockland K.S., Knutson T. Feedback connections from area MT of the squirrel monkey to areas V1 and V2. J. Comp. Neurol. 425:2000;345-368
63. Hassler R. Comparative Anatomy of the Central Visual Systems in Day-and Night-Active Primates. 1967;Plenum Press, New York. pp. 410-434
64. Spatz W.B. Topographically organized reciprocal connections between areas 17 and MT (visual area of superior temporal sulcus) in the marmoset Callithrix jacchus. Exp. Brain Res. 27:1977;559-572
65. Weller R.E., Kaas J.H. Cortical and Subcortical Connections of Visual Cortex in Primates. 1981;Humana Press, Englewood Cliffs, NJ. pp. 121-155
66. Diamond I.T., Conley M., Itoh K., Fitzpatrick D. Laminar organization of geniculocortical projections in Galago senegalensis and Aotus trivirgatus. J. Comp. Neurol. 242:1985;584-610
67. Hannun Y.A., Bell R.M. Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. Science. 235:1987;670-674
68. Suzuki K. Twenty five years of the "psychosine hypothesis": a personal perspective of its history and present status. Neurochem. Res. 23:1998;251-259
69. Tapasi S., Padma P., Setty O.H. Effect of psychosine on mitochondrial function. Ind. J. Biochem. Biophys. 35:1998;161-165
70. Mizuno Y., Sone N., Suzuki K., Saitoh T. Studies on the toxicity of 1-methyl-4-phenylpyridinium ion (MPP+) against mitochondria of mouse brain. J. Neurol. Sci. 86:1988;97-110
71. Mandybur G.T., Miyagi Y., Yin W., Perkins E., Zhang J.H. Cytotoxicity of ventricular cerebrospinal fluid from Parkinson patients: correlation with clinical profiles and neurochemistry. Neurol. Res. 25:2003;104-111
72. Lashuel H.A., Petre B.M., Wall J., Simon M., Nowak R.J., Walz T., Lansbury P.T. Jr. Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J. Mol. Biol. 322:2002;1089-1102
73. McNaught K.S., Shashidharan P., Perl D.P., Jenner P., Olanow C.W. Aggresome-related biogenesis of Lewy bodies. Eur. J. Neurosci. 16:2002;2136-2148
74. Narayanan V., Scarlata S. Membrane binding and self-association of alpha-synucleins. Biochemistry. 40:2001;9927-9934
75. Narhi L., Wood S.J., Steavenson S., Jiang Y., Wu G.M., Anafi D., Kaufman S.A., Martin F., Sitney K., Denis P., Louis J.C., Wypych J., Biere A.L., Citron M. Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. J. Biol. Chem. 274:1999;9843-9846
76. Jo E., McLaurin J., Yip C.M., St. George-Hyslop P., Fraser P.E. Alpha-synuclein membrane interactions and lipid specificity. J. Biol. Chem. 275:2000;34328-34334
77. Galvin J.E., Uryu K., Lee V.M., Trojanowski J.Q. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc. Natl. Acad. Sci. USA. 96:1999;13450-13455
78. Harding A.J., Lakay B., Halliday G.M. Selective hippocampal neuron loss in dementia with Lewy bodies. Ann. Neurol. 51:2002;125-128
79. Uchikado H., Iseki E., Tsuchiya K., Togo T., Katsuse O., Ueda K., Kato M., Kosaka K. Dementia with Lewy bodies showing advanced Lewy pathology but minimal Alzheimer pathology-Lewy pathology causes neuronal loss inducing progressive dementia. Clin. Neuropathol. 21:2002;269-277
80. Ishizawa T., Ko L.W., Cookson N., Davias P., Espinoza M., Dickson D.W. Selective neurofibrillary degeneration of the hippocampal CA2 sector is associated with four-repeat tauopathies. J. Neuropathol. Exp. Neurol. 61:2002;1040-1047
81. Sarmientos F., Schwarzmann G., Sandhoff K. Specificity of human glucosylceramide beta-glucosidase towards synthetic glucosylsphingolipids inserted into liposomes. Kinetic studies in a detergent-free assay system. Eur. J. Biochem. 160:1986;527-535
82. Vaccaro A.M., Tatti M., Ciaffoni F., Salvioli R. Factors affecting the binding of glucosylceramidase to its natural substrate dispersion. Enzyme. 42:1989;87-97
83. Dale G.L., Villacorte D.G., Beutler E. Solubilization of glucocerebrosidase from human placenta and demonstration of a phospholipid requirement for its catalytic activity. Biochem. Biophys. Res. Commun. 71:1976;1048-1053
84. Jackowski S., Wang J., Baburina I. Activity of the phosphatidylcholine biosynthetic pathway modulates the distribution of fatty acids into glycerolipids in proliferating cells. Biochim. Biophys. Acta. 1483:2000;301-315
85. Bodennec J., Pelled D., Riebeling C., Trajkovic S., Futerman A.H. Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide. FASEB J. 16:2002;1814-1816
86. Davidson W.S., Jonas A., Clayton D.F., George J.M. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273:1998;9443-9449
87. Jensen P.H., Nielsen M.S., Jakes R., Dotti C.G., Goedert M. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J. Biol. Chem. 273:1998;26292-26294
88. Wood S.J., Wypych J., Steavenson S., Louis J.C., Citron M., Biere A.L. Alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. J. Biol. Chem. 274:1999;19509-19512